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ABSTRACT                        Peptaibiotics are bioactive secondary metabolites belonging to a constantly grow-
ing family of fungal peptide antibiotics. They are linear, amphipathic oligopeptides consisting 
of 5-20 amino acids, usually containing nonproteinogenic amino acid residues as characteristic 
building blocks of the structure. The majority of the peptaibiotics described so far are produced 
by members of the filamentous fungal genus Trichoderma. Species of this genus are known as 
important sources of antibiotics and enzymes, and they are also known as promoters of plant 
growth, decomposers of xenobiotics and as commercial biofungicides.  In this work, a rapid, 
bacterium-based screening method was developed and optimized for the detection of peptai-
biotic production in liquid cultures of Trichoderma strains. The method was validated with the 
commercially available alamethicin as a peptaibiotic reference compound.
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Species of the imperfect Þlamentous fungal genus Tricho-
derma with teleomorphs belonging to the Hypocreales order 
of Ascomycota are of great economic importance as sources 
of antibiotics, enzymes, as plant growth promoters, decom-
posers of xenobiotics, and as commercial biofungicides (Chet 
and Inbar 1994; Harman et al. 2004). Hovewer, Trichoderma 
strains have also been reported in an increasing number of 
cases as etiologic agents in human infections (Kredics et al. 
2011) and as causal agents of green mould epidemics in the 
commercial production of mushrooms (Hatvani et al. 2008; 
Kredics et al. 2010).
Peptaibiotics are secondary metabolites, which constitute 
a family of fungal peptide antibiotics growing constantly 
since alamethicin was isolated from cultures of strain NRRL 
3199 of Trichoderma arundinaceum (initially identiÞed as 
T. viride) (Reusser 1967). The structure, microheterogenity 
and biological effects of this molecule were investigated over 
45 years as reviewed in details by Leitgeb et al. (2007) and 
Kredics et al. (2013). The structure and properties of a con-
siderable part of more than 1000 peptaibiotics are presented 
in the Comprehensive Peptaibiotics Database, which is freely 
available from the internet at http://peptaibiotics-database.
boku.ac.at (Stoppacher et al. 2013). Most of the peptaibiotic 
producers are fungal species from genera belonging to the 
Hypocreales order of the Ascomycota division, with members 
of the genus Trichoderma being the most important, respon-
sible for the production of about two third of these molecules 
(Szekeres et al. 2005).
Peptaibiotics are linear, amphipathic oligopeptides com-
posed of 5-20 amino acids. Their sequences contain high 
amounts of non-proteinogenic amino acid residues like 
isovaline (Iva), and A-aminoisobutyric acid (Aib), which 
are A,A-dialkylated amino acids occurring in high propor-
tions and representing characteristic building blocks of the 
structure. The N-terminal residues of these peptides are 
usually acetylated or rarely acylated, and an amino alcohol, 
mostly phenylalaninol or in certain cases valinol, leucinol, 
isoleucinol or tryptophanol is linked by a peptide bond at the 
C-terminal end (Szekeres et al. 2005). 
Because of the growing number of peptaibiotics discov-
ered, screening methods are required which provide sufÞcient 
and reliable diagnostic information on peptaibiotic production 
potential. Such assays may be based on analytical or biologi-
cal methodologies. The characteristic amino acid residues and 
amino alcohols could be used to monitor the peptaibiotic 
production of biocontrol Trichoderma strains based on the gas 
chromatographic separation of their crude mycelial extracts 
after acidic hydrolysis (Solfrizzo et al. 1994). Krause et al. 
(2006) also presented a chromatographic screening method 
enabling the sensitive detection of fungal peptides with Aib 
content. Their method comprises solid-phase extraction and 
preconcentration procedure followed by on-line reversed-
phase high performance liquid chromatography (HPLC) 
coupled to electrospray ionization tandem mass spectrometry, 
where the presence of the marker amino acid Aib was detected 
by characteristic mass differences of fragment ions of 85.1 Da 
(Aib-H2O) on the mass spectra (Krause et al. 2006). 
Peptaibiotics exert a broad range of biological activities 
depending on their chain length and particular structural 
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features (Szekeres et al. 2005), which could also be utilized 
for their detection. They have been described to exhibit an-
tibacterial activity against Gram-positive bacteria and wall-
less bacteria (Dornberger et al. 1995; Leclerc et al. 2001), 
and display antifungal (Dornberger et al. 1995; Berg et al. 
1996) as well as antiviral activities (Kim et al. 2000; Yun 
et al. 2000). The bioactivity of peptaibiotics also includes 
toxicity towards mammalian cells (Peltola et al. 2004) and 
insecticidal action on larvae (Matha et al. 1992; Bandani et 
al. 2001; Landreau et al. 2002). 
Based on the literature, the best choice for the detection 
of fungal peptaibiotic production is the sequential combina-
tion of a sensitive and low-cost biological pre-screening 
assay followed by a sophisticated analytical technique. In 
accordance with this strategy, the present work describes the 
development and optimization of a rapid, bacterium-based 
method for the pre-screening of fungal ferment broth extracts 
for peptaibiotic production.
Materials and Methods
Strains and culture conditions 
The examined 30 Trichoderma strains were derived from the 
the Microbiological Collection of the University of Szeged 
(SZMC; Table 1) and were maintained on yeast extract me-
dium (YE: 2 g l1 yeast extract, 5 g l1 KH2PO4, 20 g l1 agar 
in tap water) at 25¡C. The isolates were identiÞed previously 
based on their internal transcribed spacer (ITS) sequences 
using the TrichOkey 2.0 online barcoding program (www.
isth.info, Druzhinina et al. 2005). 
The Bacillus subtilis (SZMC 0209), Escherichia coli 
(SZMC 0582), Micrococcus luteus (SZMC 0264) and Ser-
ratia marcescens (SZMC 0567) strains also derived from 
the SZMC culture collection and were maintained on LB 
(Luria-Bertani) agar medium (10 g l1 tryptone, 5 g l1 yeast 
extract, 10 g l1 NaCl and 20 g l1 agar-agar) at 37 C¡ with 
weekly subculturing.
Isolate code Location of isolation Species
Pre-
screening 
test  result
Inhibition zone 
in mm (alamethicin 
equivalent in Mg/ml)
SZMC 1012 wheat rhizosphere, Deszk T. longibrachiatum - -
SZMC 1628 wheat rhizosphere, Rúzsa T. brevicompactum - -
SZMC 1631 wheat rhizosphere, Rúzsa T. rossicum - -
SZMC 1649 wheat rhizosphere, Rúzsa T. spirale - -
SZMC 1656 wheat rhizosphere, Rúzsa T. gamsii - -
SZMC 1762 Agaricus compost, Hungary T. ghanense - -
SZMC 1813  (CBS 100527) Agaricus compost, North-America T. aggressivum f. ag-gressivum - -
SZMC 1811  (CBS 433.95) Agaricus compost, Great-Britain T. aggressivum f. euro-paeum - -
SZMC 1746 Agaricus compost, Hungary T. aggressivum f. euro-paeum - -
SZMC 12498 wild growing Agaricus sp., fruiting body T. atroviride + 8 (67.71)
SZMC 1886 wild growing Agaricus sp., fruiting body T. tomentosum + 12.5 (139.07)
SZMC 12617 wild growing Agaricus sp., fruiting body T. citrinoviride + 8 (67.71)
SZMC 1873 wild growing Agaricus sp., fruiting body T. hamatum - -
SZMC 1881
SZMC 1885 
SZMC 12492 
SZMC 1880 
SZMC 12487
SZMC 1874)
wild growing Agaricus sp., fruiting body T. harzianum
-
-
+
-
-
+
-
-
12.5 (139.07)
-
-
15 (207.45)
 SZMC 1884 wild growing Agaricus sp., fruiting body T. koningii - -
SZMC 12500 wild growing Agaricus sp., fruiting body T. koningiopsis - -
SZMC 12727 wild growing Agaricus sp., fruiting body T. pleuroticola + 11.5 (118.51)
SZMC 12454 Pleurotus compost T. pleurotum + 50 (OCR)
SZMC 1718 - T. velutinum - -
SZMC 12515 wild growing Agaricus sp., fruiting body T. virens + 38 (OCR)
SZMC 12553 (CNM-CM-2171) clinical T. longibrachiatum - -
SZMC 12554 (CNM-CM-2277 clinical T. longibrachiatum - -
SZMC 1775 (IMI 291914) Antarctica T. longibrachiatum - -
SZMC 1776 (CECT 20105) Biocontrol strain, Spain T. longibrachiatum - -
SZMC 1773 (CECT 2412) Agaricus compost, Wales T. longibrachiatum + 14 (176.78)
Table 1. Trichoderma strains involved in the experiments.
OCR: out of calibration range.
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Testing of inhibitory effects of crude extracts on 
bacteria
Four different species of bacteria (B. subtilis, E. coli, M. 
luteus and S. marcescens) were involved in the initial test of 
antibacterial effects in the case of the crude ferment broths 
and mycelial extracts of 15 tested Trichoderma isolates (T. 
aggressivum f. aggressivum SZMC 1813, T. atroviride SZMC 
12498, T. brevicompactum SZMC 1628, T. citrinoviride 
SZMC 12617, T. cerinum SZMC 1886, T. gamsii SZMC 
1656, T. ghanense SZMC 1762, T. hamatum SZMC 1873, T. 
harzianum SZMC 1874, SZMC 12487 and SZMC 12492, T. 
koningiopsis SZMC 12500, T. rossicum SZMC 1631, T. spi-
rale SZMC 1649 and T. virens SZMC 12515). Trichoderma 
strains were grown in shaken (rotary shaker, 200 rpm) or 
standing cultures in liquid yeast extract-glucose medium 
(YEG: YE + 10 g l1 glucose) for 5 days. Mycelia and the 
lyophilized ferment broths were separately dissolved in 5 and 
2 ml methanol, respectively.
Agar plates were prepared containing 20 ml media cor-
responding to the test organisms: beef extract agar (BEA) 
medium (4 g l1 beef extract, 4 g l1 peptone, 10 g l1 glucose, 
1 g l1 yeast extract and 20 g l1 agar) for B. subtilis and S. 
marcescens, and LB agar medium for E. coli and M. luteus. 
Bacteria were mixed into 5 ml covering agar (BEA or LB 
with 10 g l1 agar) at 40¡C and poured onto the surface of 
the base medium. 
Fifty Ml amounts of the methanolic extracts of the Tricho-
derma ferment broths were Þlled into holes (5 mm in diam-
eter) bored into the surface of the agar plates. The diameter 
of the inhibition zones were observed and recorded after 2 
days of incubation at 37¡C. After the selection of the test bac-
terium and the optimization of bacterial pre-cultivation time 
and inoculated cell density (see below), the above procedure 
was applied under optimal conditions for the entire set of 
Trichoderma isolates.
Optimization of bacterial pre-cultivation 
time and inoculated cell density in the pre-
screening system
The ferment broths deriving from shaken cultures of two 
Trichoderma strains showing antibacterial effects in the initial 
test, T. citrinoviride SZMC 12617 and T. virens SZMC 12515 
were tested. The Trichoderma strains were grown in shaken 
cultures in liquid YEG medium for 5 days. After culturing, 
a 2 ml chloroform extract was made from 2 ml of ferment 
broth, evaporated and Þnally dissolved in 100 µl methanol, 
and 50 µl of that extract was used in the optimization of the 
assay with M. luteus. 
The examined M. luteus strain was precultured on LB agar 
medium at 37¡C for different periods of time (1, 2, 3, 4, 5 and 
6 days). For the purposes of pour plating, a suspension was 
prepared from M. luteus in physiological salt solution. The 
cell concentration of the suspension was determined with the 
aid of a calibration curve after the measurement of the optical 
density (OD) of the suspensions at 620 nm. The calculated 
amounts (105, 2s105, 3s105, 4s105, 5s105, 106,1.5s106, 2s106 
and 3s106 cells) of the M. luteus suspension were mixed at 
40¡C into 5 ml molten LB agar medium containing 10 g l1 
agar, which was subsequently poured onto the surface of the 
base LB agar medium. Finally, holes of 5 mm in diameter 
were bored into the surface of the LB agar plates and 50 µl 
amounts of the extracts were Þlled into them. The diameters 
of the inhibition zones were observed and recorded in mm 
along two perpendicular axes after 1 and 2 days of incuba-
tion at 37¡C.
Calibration of inhibitory effects
An accurately weighed amount (5 mg) of alamethicin (Sigma, 
Hungary) was placed separately in a 5 ml volumetric ßask and 
dissolved in methanol (VWR, Hungary) to produce a 1000 µg 
ml-1 standard stock solution. This stock solution was diluted 
serially with methanol, revealing a solution series with the 
concentrations of 500.00, 250.00, 125.00, 62.50, 31.25, 15.63, 
7.81 and 3.91 µg ml-1. Fifty µl amounts of the solutions were 
Þlled into holes (5 mm in diameter) bored into the surface 
of LB agar plates inoculated with 105 M. luteus cells. The 
diameters of the inhibition zones were observed and recorded 
as described above. Three replicates were performed and the 
mean of the recorded values was used for the calibration. The 
resulting calibration curve was used to express the inhibi-
tory effect of the examined Trichoderma ferment broths as 
Õalamethicin equivalentÕ.
Results
Selection of the bacterial strain
Initially, four different bacterial strains (B. subtilis SZMC 
0209, E. coli SZMC 0582, M. luteus SZMC 0264 and S. 
marcescens SZMC 0567) were tested with extracts of fer-
ment broths and mycelia of standing and shaken cultures of 
15 Trichoderma strain. Inhibition zones were detected in the 
case of B. subtilis for 15 samples (standing culture, mycelium: 
SZMC 1649, 1656, 1631, standing culture, ferment broth: 
SZMC 12500, shaken culture, mycelium: SZMC 1649, 1873, 
12492, 1631, 1874, shaken culture, ferment broth: SZMC 
1631, 12500, 1813, 12492, 1873, 1874), in the case of E. 
coli for 6 samples (standing culture, ferment broth: SZMC 
1873, 12515, 1656, 1886, 12498, 12500), in the case of M. 
luteus for 12 samples (standing culture, mycelium: SZMC 
12617, standing culture, ferment broth: SZMC 12515, 1762, 
1649, shaken culture, mycelium: SZMC 1873, 12492, 1631, 
1874, shaken culture, ferment broth: SZMC 12515, 12617, 
1873, 12498), and in the case of S. marcescens for 9 samples 
(standing culture, mycelium: SZMC 1762, 1649, standing 
culture, ferment broth: SZMC 12500, 1886, 12515, 12617, 
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1813, 1631, 1656). Altogether, the largest inhibition zones 
were detected in the case of ferment broth extracts of shaken 
cultures on M. luteus therefore these conditions were selected 
for the optimization of the biological pre-screening test. 
Effect of the pre-cultivation period and bacterial 
cell density on the inhibitory effects 
Based on the initial test, two antibacterial strains of Trichoder-
ma species, T. citrinoviride SZMC 12617 and T. virens SZMC 
12515 were selected for the optimization of the culture age 
of the test bacteria and the applied concentration of the cells. 
One, 2, 3, 4, 5 or 6 days old M. luteus cultures were applied 
in different amounts (105, 2s105, 3s105, 4s105, 5s105, 106, 
1.5s106, 2s106 and 3s106 cells, Table 2, Figure 1). Bacteria 
pre-cultured for 1, 2 and 3 days formed a merged bacterial 
lawn in contrast to the bacteria pre-cultured for 4, 5 and 6 
days, where it was not possible to unambiguously determine 
the size of the inhibition zone after 1 or 2 days of incubation 
(Figure 1). Consequently, the pre-culturing time should be 
less than 3 days. However, there are signiÞcant differences 
between the size of the inhibition zones after different pre-
culturing times. In the case of T. citrinoviride SZMC 12617, 
the largest zones could be detected for most of the bacterial 
concentrations, when the bacteria were pre-cultured for 2 
days (Table 2). Altogether, the increasing concentration of 
test bacteria caused decreasing diameters of the inhibition 
zone. The test was not working under the cell concentration 
of 105 M. luteus cells ml-1 as the inhibition zones were not 
unambiguous due to the low cell number. In conclusion, pre-
culturing of M. luteus for 2 days and applying 105 cells per 
plate proved to be the optimal conditions. 
Inhibitory properties of alamethicin in the pre-
screening system
The effect of alamethicin as a peptaibiotic reference compund 
was tested on M. luteus at different concentrations (Fig. 2). 
The 500.0, 250.0, 125.0 and 62.5 µg ml1 levels of the alame-
thicin dilution resulted in mean inhibition zones of 19.8, 16.2, 
10.6 and 7.3 mm (limit of quantitation, LOQ), respectively, 
while the further dilution steps with lower concentrations 
showed no measurable inhibitory effect on M. luteus (Figure 
3). The relative standard deviations (RSD) of the repeated 
tests (n=3) were below 10%, and the accuracy of the regres-
sion line was below ±5%, while the limit of detection was at 
the level of 31.25 µg ml1 with low visibility. 
Screening the ferment broths of the 
Trichoderma isolates under the optimized 
conditions
The optimized test was applied to test 30 strains of Tricho-
Figure 1. Inhibition zones of extracts of Trichoderma virens strain SZMC 
12515 on solid medium inoculated with 2x105 cells of Micrococcus 
luteus. The bacteria were pre-cultured for 1 (A1), 2 (A2), 3 (B1), 4 (B2, 
C), 5 (D1) and 6 (D2) days and the results were recorded after one (A1, 
A2, B1, B2) and two (C, D1, D2) days of incubation at 37°C.
T. virens
SZMC 12515
Age of Micrococcus luteus (days)
Cell number (x106) 1 2 3 4
0.1 33 38 36 42
0.2 34 37 38 40
0.3 33 35 35 45
0.4 32 33 35 45
0.5 31 33 35 44
1 27 33 35 36
1.5 31 32 30 36
2 27 28 29 37
3 29 32 23 35
T. citrinoviride 
SZMC 12617
Age of Micrococcus luteus (days)
Cell number (x106) 1 2 3 5 6
0.1 38 50 36 33 52
0.2 37 43 32 34 47
0.3 36 38 32 31 43
0.4 38 33 33 31 43
0.5 33 35 32 31 43
1 28 35 35 27 40
1.5 31 34 32 28 37
2 28 34 27 27 32
3 27 31 28 30 32
Table 2. Effect of pre-cultivation time and applied cell amount 
of  Micrococcus luteus on the diameter of the inhibition zones 
(mm) caused by the ferment broth extracts of strains Tricho-
derma virens SZMC 12515 and Trichoderma citrinoviride SZMC 
12617.
ND: not determined
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derma listed in Table 1. The test proved to be positive for 9 
strains: T. atroviride SZMC 12498, T. tomentosum SZMC 
1886, T. citrinoviride SZMC 12617, T. harzianum SZMC 
12492, SZMC 1874, T. pleuroticola SZMC 12727, T. pleuro-
tum SZMC 12454, T. virens SZMC 12515 and T. longibrachi-
atum SZMC 1773 (CECT 2412) with inhibition zones of 10, 
19, 8, 12, 15, 14, 8, 38 and 16 mm in diameter, respectively 
(Table 1). No antibacterial effects could be detected for the 
other 21 strains under the applied test conditions. 
Discussion
In this study we report the development and optimization 
of a rapid bioactivity-based pre-screening method for the 
detection of peptaibiotic production in Trichoderma strains. 
Bioactivity-based assays for the study of peptaibiotics have 
been applied in previous studies. The toxic effects of peptai-
biotics were already applied in their detection and correlation 
was found beetween the peptaibiotic production and the bio-
logical activity in the case of brine shrimp (Artemia salina) 
(Solfrizzo et al. 1994) and blowßy larvae (Phormia terrae 
novae) (Landreau et al. 2002). Poirier et al. (2007) performed 
embryotoxicity bioassays with oysters (Crassostrea gigas) in 
order to assess the acute toxicity of alamethicin and different 
groups of peptaibiotics produced by a T. longibrachiatum 
strain isolated from marine environment. Alamethicin and a 
mixture of long and short-sequence peptaibiotics were shown 
to disturb the embryogenesis of C. gigas in the nanomolar 
concentration range. Although statistically signiÞcant differ-
ences were not observed among the applied three groups of 
peptaibiotics because of the remarkable variations between 
replicates, toxic effects based on the estimation of EC50 ap-
peared appreciably different. However, compared to the short-
sequence peptaibiotic mixture, long-sequence peptaibiotics 
were associated with a higher toxicity and the abnormality 
effects of alamethicin were between them. The initial peptai-
biotic concentrations in all of the three groups of the tested 
peptaibiotics were signiÞcantly correlating with the abnor-
mality of embryogenesis by a non-linear regression (Poirier 
et al. 2007). Boar spermatozoa have also been successfully 
used as tools in the search for peptaibotics from T. harzianum 
(Peltola et al. 2004), T. longibrachiatum (Mikkola et al. 2012) 
and Acremonium exuviarum (Andersson et al. 2008). 
Trichoderma species, the tested isolates of which proved 
to be positive in the bacterium-based test optimized during 
this study were T. atroviride, T. citrinoviride, T. harzianum 
(2 strains), T. longibrachiatum, T. pleuroticola, T. pleurotum, 
T. tomentosum and T. virens. Among them, T. atroviride is 
known from the literature to produce atroviridins (Oh et al. 
2000), neoatroviridins (Oh et al. 2005) and trichoatrokontins 
(Stoppacher et al. 2008), T. citrinoviride to produce para-
celsins (Pcsfalvi et al. 1997) and other 20-residue peptides 
from the paracelsin family (Maddau et al. 2009), T. longibra-
chiatum to produce trichobrachins (Mohamed-Benkada et al. 
2006; Ruiz et al. 2007), trichorovin (Mohamed-Benkada et 
al. 2006) and trilongins (Mikkola et al. 2012), while T. virens 
to produce trichorzins (Wiest et al. 2002) as well as 11- and 
14-residue peptaibiotics (Mukherjee et al. 2011). A series of 
peptaibiotic compounds could be isolated previously also 
from T. harzianum strains, including harzianins (Rebuffat et 
al. 1995), trichokindins (Iida et al. 1994), trichorozins (Iida et 
al. 1995), trichorzianins (El Hajji et al. 1987; Rebuffat et al. 
1989; Pcsfalvi et al. 1998), trichorzins (Goulard et al. 1995; 
Duval et al. 1997) and trichotoxins (Suwan et al. 2000).
The isolates of the other tested species, T. aggressivum f. 
aggressivum, T. aggressivum f. europaeum, T. brevicompac-
tum, T. gamsii, T. ghanense, T. rossicum and T. spirale were 
negative under the test conditions. Among these species, T. 
brevicompactum is well-known for its ability to produce 
Figure 2. Calibration curve prepared with alamethicin as peptaibiotic 
reference compound.
Figure 3. Effect of serial dilution steps of alamethicin on Micrococcus 
luteus: (A) 500.0 µg ml-1, (B) 250.0 µg ml-1, (C) 125.0 µg ml-1, (D) 62.5 
µg ml-1, (E) 31.25 µg ml-1, (F) 15.63 µg ml-1, (G) 7.81 µg ml-1 and (H) 
3.91 µg ml-1.
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a series of peptaibiotics (trichobrevins, trichocompactins, 
trichocryptins, trichoferins) (Degenkolb et al. 2006), and T. 
aggressivum f. europaeum was also shown to produce short 
peptaibiotics (Krause et al. 2006). However, it can be sup-
posed that not all isolates of a particular species are capable 
of peptaibiotic production, furthermore, the production may 
also depend from the culture conditions.
To conÞrm our results on the suspected presence or ab-
sence of peptaibiotic production, detailed analytical examina-
tions will be carried out based on characteristic amino acid 
residues of known peptaibiotics such as A-aminoisobutyric 
acid and isovaline. Although it is possible that the pre-screen-
ing method described here detects not just peptaibiotics but 
also other antibacterial compounds of non-peptaibiotic nature, 
the known effects of peptaibiotics on Gram-positive bacteria 
(Dornberger et al. 1995; Leclerc et al. 2001; Szekeres et al. 
2005) suggest that this method may prove to be a powerful as 
well as time- and cost-consuming tool for the pre-screening 
of large numbers of fungal isolates for peptaibiotic produc-
tion.
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